{"url_path":"/sec/algs/8-k/2026-06-26/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/1799448/0001193125-26-285426-index.html","accession_number":"0001193125-26-285426","cik":"0001799448","ticker":"ALGS","issuer_name":"Aligos Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1799448/0001193125-26-285426-index.html","primary_entity_key":"0001799448","primary_entity_name":"Aligos Therapeutics, Inc."},"word_count":93,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\nNo.\n  \n\nDescription\n\n10.1\n  \n[Amendment to the Aligos Therapeutics, Inc. 2020 Employee Stock Purchase Plan.](d70452dex101.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nALIGOS THERAPEUTICS, INC.\n\nDate: June 26, 2026\n \n\n \nBy:\n \n\n/s/ Lesley Ann Calhoun\n\n \n\n \n\n \nLesley Ann Calhoun\n\n \n\n \n\n \nExecutive Vice President, Chief Operating Officer and Chief Financial Officer"}